Our Leadership team is comprised of a mix of innovative, experienced, and scientific-minded leaders who have set the tone for GenomOncology's ambitious and driven culture.
Chief Executive Officer
Formerly the President and COO of Rosetta, Brad Wertz helped grow the company from $115M to $225M before its sale to Publicis. Before Rosetta, He served as COO for Brulant and also held senior executive positions at several other startups including bioinformatics company Acero.
Chief Operating Officer
Gina Drobnick has more than 25 years of experience as both a management consultant and an operations executive. Gina also worked at Ernst & Young, Arthur Andersen, Brulant as an Associate Partner in their creative group, and Level Seven, Inc. as their Chief Operating Officer.
VP of Product Development
Justin Yeakley supports and supervises all activities related to the design, development, and implementation of GO's suite of products. Justin has over 12 years of software development and leadership experience and was previously Director of Application Development at Rosetta.
TERESA FLETCHER, CHP
Senior VP of Business Development
Teresa Fletcher is a seasoned business development professional with a deep understanding of oncology and the healthcare ecosystem. Teresa has over 17 years experience with enterprise solution sales holding positions at various healthcare startups within sales and customer management.